Narcotics vs NSAIDs for Post-operative Analgesia in Outpatient Rhinoplasty



Status:Enrolling by invitation
Conditions:Cosmetic
Therapuetic Areas:Dermatology / Plastic Surgery
Healthy:No
Age Range:18 - 70
Updated:2/23/2019
Start Date:January 30, 2018
End Date:January 1, 2020

Use our guide to learn which trials are right for you!

Narcotics vs Non-steroidal Ant Inflammatory Drugs Post-operative Analgesia in Outpatient Rhinoplasty

The purpose of this study is to compare the efficacy and safety of oral opiate pain
medication vs non-steroidal ant inflammatory drugs (NSAIDs) in the treatment of postoperative
rhinoplasty pain. This study will also evaluate potential contributing factors affecting the
efficacy of these pain control methods. Patients will be randomized to receive either NSAIDs
in the form of 400mg of Ibuprofen or Norco (hydrocodone 5mg- acetaminophen 325mg) to be used
for post-operative pain. The study will then compare which is more effective in controlling
post operative pain.


Inclusion Criteria:

- Patients 18-70 years old undergoing septorhinoplasty or rhinoplasty for either
obstructive or aesthetic reasons. All approaches to rhinoplasty and surgical
techniques utilized will be included. This will include patients that undergo
additional procedures during the rhinoplasty including osteotomies, turbinate
reduction, septoplasty, nasal valve repair and ear cartilage graft.

Exclusion Criteria:

- Patients who undergo a rhinoplasty requiring a rib cartilage graft for the procedure
as this is known to cause significant pleuritic chest pain.

- Patients receiving functional endoscopic sinus surgery concurrently with the
rhinoplasty will be excluded.

- Patients with known history of gastrointestinal bleeds, peptic ulcer disease or who
have other comorbidities that prevent them from taking NSAIDs.

- Patients with a history of radiation, active head and neck malignancy or other pain
disorders such as various rheumatologic diseases will be excluded to decrease
confounding factors in the control of pain.
We found this trial at
1
site
New York, New York 10016
Principal Investigator: Judy Lee, MD
Phone: 212-263-8182
?
mi
from
New York, NY
Click here to add this to my saved trials